Novartis
NVS
NVS
908 hedge funds and large institutions have $19.9B invested in Novartis in 2017 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 342 increasing their positions, 334 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 903 → 908 (+5)
5% less funds holding in top 10
Funds holding in top 10: 21 → 20 (-1)
55% less call options, than puts
Call options by funds: $30.9M | Put options by funds: $68.2M
Holders
908
Holding in Top 10
20
Calls
$30.9M
Puts
$68.2M
Top Buyers
| 1 | +$361M | |
| 2 | +$280M | |
| 3 | +$210M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$130M |
| 5 |
Millennium Management
New York
|
+$102M |
Top Sellers
| 1 | -$239M | |
| 2 | -$104M | |
| 3 | -$81.4M | |
| 4 |
Lazard Asset Management
New York
|
-$47.6M |
| 5 |
MHI
Miller Howard Investments
Kingston,
New York
|
-$46.6M |